Showing results (511-520 of 24,158) with videos related to
Sort By:
Pageof 2,416
Medical Hypotheses|December 4, 2014
Bruch's membrane diffusivity for vascular endothelial growth factors may explain variable response to wet age-related macular degeneration treatment: clinical implicationsRam R PeddadaEuroasian Journal of Hepato-Gastroenterology|December 22, 2017
Feasibility of Concurrent Chemoradiation in Patients treated for Esophageal Carcinoma: A Single Institutional ExperienceRam Abhinav KannanJournal of Manipulative and Physiological Therapeutics|June 15, 2014
Instantaneous rate of loading during manual high-velocity, low-amplitude spinal manipulationsMaruti Ram GudavalliEnvironmental Science and Pollution Research International|April 11, 2021
Concentrations of serum hydroxycotinine for US adult smokers aged ≥ 20 years by type of smokerRam B JainACS Medicinal Chemistry Letters|May 17, 2023
Novel Imidazotriazine Derivatives as IL-17 Modulators for Treating Inflammatory and Autoimmune DisordersRam W SabnisEnvironmental Science and Pollution Research International|June 25, 2020
Concentrations of serum cotinine across stages of glomerular function among US adult smokers and nonsmokersRam B JainACS Medicinal Chemistry Letters|November 19, 2025
Novel 1,4-Dihydro-2H-pyrano[3,4‑<i>c</i>]quinoline Compounds for Treating Bacterial Infections, Tuberculosis, or LeprosyRam W SabnisACS Medicinal Chemistry Letters|July 16, 2025
Novel Amido Heteroaromatic Compounds as 17βHSD13 Inhibitors for Treating Liver Disease, Namely, NASHRam W SabnisACS Medicinal Chemistry Letters|July 16, 2025
Novel Indole Derivatives as Serotonergic Psychedelic Agents for Treating Psychosis, Mental Illness, and CNS DisordersRam W SabnisACS Medicinal Chemistry Letters|July 16, 2025
Novel N‑Substituted Indole Derivatives as Serotonergic Psychedelic Agents for Treating Psychosis, Mental Illness, and CNS DisordersRam W SabnisPageof 2,416